Aurobindo Pharma buys Khandelwal Labs unit for ₹325 cr

Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.

Tata Motors Sales Jump 25% in December 2024

Tata Motors announces robust December 2024 sales, registering a 25% year-on-year growth. Discover the key drivers behind this impressive performance and the outlook for 2025.

5 Indian Sectors Beat Nifty in Volatile 2025 Market

Despite a tough 2025 for Indian equities, five sectors soared: PSU Banks, Metals, Auto, Defence, and Private Banks. Discover the drivers behind their stellar performance and what it means for investors.

Rupee dips 10 paise to 89.98 vs USD on FII outflows

The Indian rupee depreciated 10 paise to close at 89.98 against the US dollar on Thursday, pressured by foreign fund outflows and a flat equity market. Read the full analysis of the currency's weak start to 2026.

Page 1059 of 1490
Pickt mobile sticky banner — logo, tagline and CTA button